GLIOBLASTOMA MULTIFORME
Clinical trials for GLIOBLASTOMA MULTIFORME explained in plain language.
Never miss a new study
Get alerted when new GLIOBLASTOMA MULTIFORME trials appear
Sign up with your email to follow new studies for GLIOBLASTOMA MULTIFORME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Novartis halts early trial of targeted radiation drug for tough cancers
Disease control TerminatedThis was an early-stage study to test the safety and find the right dose of a new radioactive drug called 177Lu-FF58 for people with advanced pancreatic, stomach, or brain cancer. The drug is designed to deliver radiation directly to tumors. The study was terminated early, and it…
Matched conditions: GLIOBLASTOMA MULTIFORME
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Apr 03, 2026 22:56 UTC
-
New drug tested as last hope for aggressive brain cancer
Disease control TerminatedThis study tested an experimental drug called VAL-083 for adults with glioblastoma, a fast-growing brain cancer that had returned after standard treatments failed. It compared VAL-083 against a doctor's choice of other approved chemotherapy drugs to see which helped patients live…
Matched conditions: GLIOBLASTOMA MULTIFORME
Phase: PHASE3 • Sponsor: DelMar Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New imaging tracer tested to light up Hard-to-See cancers
Diagnosis TerminatedThis early-stage study tested a new imaging agent called [68Ga]-FF58. The goal was to see if this tracer could effectively highlight specific aggressive cancers—including brain, stomach, and pancreatic tumors—during a PET scan. A small group of adult patients with these cancers r…
Matched conditions: GLIOBLASTOMA MULTIFORME
Phase: EARLY_PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Diagnosis
Last updated Apr 03, 2026 14:43 UTC
-
Old drug, new target: can a fungus fighter slow brain cancer?
Knowledge-focused TerminatedThis small, early-stage study aimed to see if a common antifungal drug called posaconazole could get into brain tumors at high enough levels to potentially stop cancer cells from growing. Researchers gave the drug to a few adults with a type of aggressive brain cancer before thei…
Matched conditions: GLIOBLASTOMA MULTIFORME
Phase: EARLY_PHASE1 • Sponsor: Milton S. Hershey Medical Center • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:42 UTC
-
Old drug, new target: can a common pill fight deadly brain cancer?
Knowledge-focused TerminatedThis very early study aimed to see if ketoconazole, a drug used for fungal infections, could get into brain tumors at high enough levels to potentially stop cancer cell growth. Researchers planned to measure drug levels directly in the tumor tissue of a small number of adults wit…
Matched conditions: GLIOBLASTOMA MULTIFORME
Phase: EARLY_PHASE1 • Sponsor: Milton S. Hershey Medical Center • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC